Investigación / Grupos de investigación

Grupo  401

Microbiología clínica y enfermedades Infecciosas

Publicaciones (1283)

  • Del Romero, J; Guillén, SM; Rodríguez-Artalejo, F; Ruiz-Galiana, J; Cantón, R; Ramos, PD; García-Botella, A; García-Lledo, A; Hernández-Sampelayo, T; Gómez-Pavon, J; del Castillo, JG; Martín-Delgado, MC; Sánchez, FJM; Martinez-Sellés, M; Garcia, JMM; Castellá, JG; Palomo, M; Berrio, RG; González, AC; Sotomayor, C; Bouza, E.

    Sexually transmitted infections in Spain: Current status

    Revista Espanola de Quimioterapia. 2023; 36(5): 444-465 Nº de citas: 12 [doi:10.37201/req/038.2023]

  • Martinez-Selles, M; Sánchez, FJM; Guillén, SM; Rodríguez-Artalejo, F; Ruiz-Galiana, J; Cantón, R; Ramos, PD; García-Botella, A; García-Lledó, A; Hernández-Sampelayo, T; Gómez-Pavón, J; del Castillo, JG; Martín-Delgado, MC; García, JMM; Santiago, B; Caminero, JA; Barros, C; de Viedma, DG; Martín, C; Bouza, E.

    Advantages and disadvantages of maintaining the mandatory use of masks in health centers and nursing homes in Spain. How and when is it justified to maintain it?

    Revista Espanola de Quimioterapia. 2023; 36(5): 466-469 Nº de citas: 2 [doi:10.37201/req/070.2023]

  • El Mammery, A; de Arellano, ER; Cañada-García, JE; Cercenado, E; Villar-Gómara, L; Casquero-García, V; García-Cobos, S; Lepe, JA; Bordes, ERD; Calvo-Montes, J; Escartín, NL; Cantón, R; Pérez-Vázquez, M; Aracil, B; Oteo-Iglesias, J; Spanish EARS-Net Grp.

    An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004-2020)

    Frontiers in Microbiology. 2023; 14: Nº de citas: 15 [doi:10.3389/fmicb.2023.1220286]

  • Herranz, M; Buenestado-Serrano, S; Martín-Escolano, J; Molero-Salinas, A; Alonso, R; Catalán, P; Muñoz, P; de Viedma, DG; Pérez-Lago, L.

    Alternative molecular and genomic strategies to provide a rapid response to alerts concerning the introduction of new emerging SARS-CoV-2 variants: the Omicron alert

    Microbiology Spectrum. 2023; 11(5): [doi:10.1128/spectrum.01075-23]

  • Mellinghoff, SC; Bruns, C; Albertsmeier, M; Ankert, J; Bernard, L; Budin, S; Bataille, C; Classen, AY; Cornely, FB; Couvé-Deacon, E; Ferrer, MF; Fortún, J; Galar, A; Grill, E; Guimard, T; Hampl, JA; Wingen-Heimann, S; Horcajada, JP; Köhler, F; Koll, C; Mollar, J; Muñoz, P; Pletz, MW; Rutz, J; Salmanton-García, J; Seifert, H; Serracino-Inglott, F; Soriano, A; Stemler, J; Vehreschild, JJ; Vilz, TO; Naendrup, JH; Cornely, OA; Liss, BJ.

    Staphylococcus aureus surgical site infection rates in 5 European countries

    Antimicrobial Resistance and Infection Control. 2023; 12(1): Nº de citas: 10 [doi:10.1186/s13756-023-01309-w]

  • Vázquez-Cuesta, S; García, NL; Fernández, AI; Olmedo, M; Kestler, M; Alcalá, L; Marín, M; Bermejo, J; Díaz, FFA; Muñoz, P; Bouza, E; Reigadas, E; HGUGM Microbiome Grp.

    Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection

    Frontiers in Cellular and Infection Microbiology. 2023; 13: Nº de citas: 6 [doi:10.3389/fcimb.2023.1237500]

  • Bouza, E; Guillen-Zabala, H; Rojas, A; Canada, G; Cercenado, E; Sanchez-Carrillo, C; Martin-Rabadan, P; Diez, C; Puente, L; Munoz, P; Galar, A.

    Comparative study of the etiology of nosocomial bacteremic pneumonia in ventilated and non-ventilated patients: a 10-year experience in an institution

    Microbiology Spectrum. 2023; 11: Nº de citas: 4 [doi:10.1128/spectrum.01517-23]

  • Gracia-Ahufinger, I; Lopez-Gonzalez, L; Vasallo, FJ; Galar, A; Siller, M; Pitart, C; Bloise, I; Torrecillas, M; Gijon-Cordero, D; Vinado, B; Castillo-Garcia, J; Campo, R; Mulet, X; Madueno-Alonso, A; Chamizo-Lopez, FJ; Arrastia-Erviti, M; Galan-Sanchez, F; Fernandez-Quejo, M; Rodriguez-Diaz, JC; Gutierrez-Zufiaurre, MN; Rodriguez-Maresca, MA; Ortega-Lafont, MD; Yague-Guirao, G; Chaves-Blanco, L; Colomina-Rodriguez, J; Vidal-Acuna, MR; Portillo, ME; de Luna, FFA; Centelles-Serrano, MJ; Azcona-Gutierrez, JM; Campero, ADIG; Rey-Cao, S; Munoz, P; Calvo-Montes, J; Zboromyrska, Y; Grandioso, D; Camara, J; Canton, R; Larrosa-Escartin, N; Diaz-Reganon, J; Martinez-Martinez, L.

    The CARBA-MAP study: national mapping of carbapenemases in Spain (2014-2018)

    Frontiers in Microbiology. 2023; 14: Nº de citas: 16 [doi:10.3389/fmicb.2023.1247804]

  • Ramos-Martínez, A; Domínguez, F; Muñoz, P; Marín, M; Pedraz, A; Fariñas, MC; Tascón, V; de Alarcón, A; Rodríguez-García, R; Miró, JM; Goikoetxea, J; Ojeda-Burgos, G; Escrihuela-Vidal, F; Calderón-Parra, J.

    Clinical presentation, microbiology, and prognostic factors of prosthetic valve endocarditis. Lessons learned from a large prospective registry

    PLoS One. 2023; 18(9): Nº de citas: 21 [doi:10.1371/journal.pone.0290998]

  • Candela, A; Arroyo, MJ; Sánchez-Cueto, M; Marín, M; Cercenado, E; Méndez, G; Muñoz, P; Mancera, L; Rodríguez-Temporal, D; Rodríguez-Sánchez, B.

    Rapid Discrimination of Pseudomonas aeruginosa ST175 Isolates Involved in a Nosocomial Outbreak Using MALDI-TOF Mass Spectrometry and FTIR Spectroscopy Coupled with Machine Learning

    Transboundary and Emerging Diseases. 2023; 2023: Nº de citas: 8 [doi:10.1155/2023/8649429]

  • Sanchez-Somolinos, M; Diaz-Navarro, M; Benjumea, A; Matas, J; Vaquero, J; Muñoz, P; Sanz-Ruíz, P; Guembe, M.

    In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement

    Antibiotics-Basel. 2023; 12(9): Nº de citas: 1 [doi:10.3390/antibiotics12091445]

  • Hidalgo-Tenorio, C; Sadyrbaeva-Dolgova, S; Enriquez-Gomez, A; Munoz, P; Plata-Ciezar, A; Miro, JM; Alarcon, A; Martinez-Marcos, FJ; Loeches, B; Escrihuela-Vidal, F; Vinuesa, D; Herrero, C; Boix-Palop, L; Arenas, MD; Vazquez, EG; de las Revillas, FA; EN DALBACEN Study Grp.

    EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci

    International Journal of Antimicrobial Agents. 2023; 62(3): Nº de citas: 27 [doi:10.1016/j.ijantimicag.2023.106918]

  • Aguilera-Alonso, D; Escosa-Garcia, L; Epalza, C; Bravo-Queipo-de-Llano, B; Olteanu, FC; Cendejas-Bueno, E; Orellana, MA; Cercenado, E; Saavedra-Lozano, J.

    Antibiotic resistance in bloodstream isolates from high-complexity paediatric units in Madrid, Spain: 2013-2021

    Journal of Hospital Infection. 2023; 139: 33-43 Nº de citas: 5 [doi:10.1016/j.jhin.2023.05.021]

  • Vigil-Vazquez, S; Manzanares, A; Hernanz-Lobo, A; Carrasco-Garcia, I; del Pozo, CZ; Perez-Perez, A; Rincon-Lopez, EM; Santiago-Garcia, B; Pintado-Recarte, MD; Alonso-Fernandez, R; Sanchez-Luna, M; Navarro-Gomez, ML.

    Serologic evolution and follow-up to IgG antibodies of infants born to mothers with gestational COVID

    BMC Pregnancy and Childbirth. 2023; 23(1): Nº de citas: 7 [doi:10.1186/s12884-023-05926-6]

  • Pérez-Recio, S; Grijota-Camino, MD; Anibarro, L; Rabuñal-Rey, R; Sabria, J; Gijón-Vidaurreta, P; Pomar, V; García-Gasalla, M; Domínguez-Castellano, A; Trigo, M; Santos, MJ; Cebollero, A; Rodríguez, S; Moga, E; Penas-Truque, A; Martos, C; Ruiz-Serrano, MJ; Garcia-de-Cara, EI; Alcaide, F; Santin, M.

    Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study

    PLoS One. 2023; 18(8): Nº de citas: 4 [doi:10.1371/journal.pone.0285917]

  • Caamano, E; Velasco, L; Garcia, MV; Asencio, JM; Pineiro, P; Hortal, J; Garutti, I.

    Prognostic factors for deterioration of quality of life one year after admission to ICU for severe SARS-COV2 infection

    QUALITY OF LIFE RESEARCH. 2023; 33(1): 123-132 Nº de citas: 7 [doi:10.1007/s11136-023-03503-0]

  • Giacobbe, DR; Dettori, S; Di Pilato, V; Asperges, E; Ball, L; Berti, E; Blennow, O; Bruzzone, B; Calvet, L; Marzani, FC; Casabella, A; Choudaly, S; Dartevel, A; De Pascale, G; Di Meco, G; Fallon, M; Galerneau, LM; Gallego, M; Giacomini, M; Sáez, AG; Hänsel, L; Icardi, G; Koehler, P; Lagrou, K; Lahmer, T; White, PL; Magnasco, L; Marchese, A; Marelli, C; Marín-Arriaza, M; Martin-Loeches, I; Mekontso-Dessap, A; Mikulska, M; Mularoni, A; Nordlander, A; Poissy, J; Russelli, G; Signori, A; Tascini, C; Vaconsin, LM; Vargas, J; Vena, A; Wauters, J; Pelosi, P; Timsit, JF; Bassetti, M.

    Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

    CRITICAL CARE. 2023; 27(1): [doi:10.1186/s13054-023-04608-1]

  • Becerra-Aparicio, F; Gomez-Zorrilla, S; Hernandez-Garcia, M; Gijon, D; Siverio, A; Berbel, D; Sanchez-Carrillo, C; Cercenado, E; Rivera, A; de Malet, A; Xercavins, M; de Gopegui, ER; Canoura-Fernandez, L; Martinez, JA; Seral, C; Del Pozo, JL; Cotarelo, M; Diaz-Reganon, J; Canton, R; Oliver, A; Horcajada, JP; Ruiz-Garbajosa, P.

    Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project)

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9): 2291-2296 Nº de citas: 12 [doi:10.1093/jac/dkad234]